ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-opioid Pain Patch Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-17C1995
Home | Market Reports | Health| Health Conditions| Pain Management
Global Non opioid Pain Patch Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-opioid Pain Patch Market Research Report 2025

Code: QYRE-Auto-17C1995
Report
September 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mylan NV
TEIKOKU SEIYAKU
Hisamitsu
Johnson & Johnson
Actavis
Lingrui
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Johnson & Johnson

Non-opioid Pain Patch Market Size

The global market for Non-opioid Pain Patch was valued at US$ 684 million in the year 2024 and is projected to reach a revised size of US$ 816 million by 2031, growing at a CAGR of 2.6% during the forecast period.

Non-opioid Pain Patch Market

Non-opioid Pain Patch Market

A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
North American market for Non-opioid Pain Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-opioid Pain Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Non-opioid Pain Patch include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng, Endo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-opioid Pain Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Pain Patch.
The Non-opioid Pain Patch market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-opioid Pain Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-opioid Pain Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-opioid Pain Patch Market Report

Report Metric Details
Report Name Non-opioid Pain Patch Market
Accounted market size in year US$ 684 million
Forecasted market size in 2031 US$ 816 million
CAGR 2.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, BLUE-EMU
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-opioid Pain Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Non-opioid Pain Patch Market growing?

Ans: The Non-opioid Pain Patch Market witnessing a CAGR of 2.6% during the forecast period 2025-2031.

What is the Non-opioid Pain Patch Market size in 2031?

Ans: The Non-opioid Pain Patch Market size in 2031 will be US$ 816 million.

Who are the main players in the Non-opioid Pain Patch Market report?

Ans: The main players in the Non-opioid Pain Patch Market are Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, BLUE-EMU

What are the Application segmentation covered in the Non-opioid Pain Patch Market report?

Ans: The Applications covered in the Non-opioid Pain Patch Market report are OTC, Rx

What are the Type segmentation covered in the Non-opioid Pain Patch Market report?

Ans: The Types covered in the Non-opioid Pain Patch Market report are Lidocaine Patches, Diclofenac Patches, Indomethacin Patches, Counter-Irritant Patches, Fentanyl Patches, Others

Recommended Reports

Pain Relief Patches

Transdermal Technology

Pain Medication Markets

1 Non-opioid Pain Patch Market Overview
1.1 Product Definition
1.2 Non-opioid Pain Patch by Type
1.2.1 Global Non-opioid Pain Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Indomethacin Patches
1.2.5 Counter-Irritant Patches
1.2.6 Fentanyl Patches
1.2.7 Others
1.3 Non-opioid Pain Patch by Application
1.3.1 Global Non-opioid Pain Patch Market Value by Application (2024 VS 2031)
1.3.2 OTC
1.3.3 Rx
1.4 Global Non-opioid Pain Patch Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patch Revenue 2020-2031
1.4.2 Global Non-opioid Pain Patch Sales 2020-2031
1.4.3 Global Non-opioid Pain Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-opioid Pain Patch Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-opioid Pain Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-opioid Pain Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Pain Patch, Product Type & Application
2.7 Global Key Manufacturers of Non-opioid Pain Patch, Date of Enter into This Industry
2.8 Global Non-opioid Pain Patch Market Competitive Situation and Trends
2.8.1 Global Non-opioid Pain Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-opioid Pain Patch Players Market Share by Revenue
2.8.3 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-opioid Pain Patch Market Scenario by Region
3.1 Global Non-opioid Pain Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-opioid Pain Patch Sales by Region: 2020-2031
3.2.1 Global Non-opioid Pain Patch Sales by Region: 2020-2025
3.2.2 Global Non-opioid Pain Patch Sales by Region: 2026-2031
3.3 Global Non-opioid Pain Patch Revenue by Region: 2020-2031
3.3.1 Global Non-opioid Pain Patch Revenue by Region: 2020-2025
3.3.2 Global Non-opioid Pain Patch Revenue by Region: 2026-2031
3.4 North America Non-opioid Pain Patch Market Facts & Figures by Country
3.4.1 North America Non-opioid Pain Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-opioid Pain Patch Sales by Country (2020-2031)
3.4.3 North America Non-opioid Pain Patch Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-opioid Pain Patch Market Facts & Figures by Country
3.5.1 Europe Non-opioid Pain Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-opioid Pain Patch Sales by Country (2020-2031)
3.5.3 Europe Non-opioid Pain Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Non-opioid Pain Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-opioid Pain Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-opioid Pain Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-opioid Pain Patch Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Pain Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-opioid Pain Patch Sales by Country (2020-2031)
3.7.3 Latin America Non-opioid Pain Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Pain Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-opioid Pain Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-opioid Pain Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-opioid Pain Patch Sales by Type (2020-2031)
4.1.1 Global Non-opioid Pain Patch Sales by Type (2020-2025)
4.1.2 Global Non-opioid Pain Patch Sales by Type (2026-2031)
4.1.3 Global Non-opioid Pain Patch Sales Market Share by Type (2020-2031)
4.2 Global Non-opioid Pain Patch Revenue by Type (2020-2031)
4.2.1 Global Non-opioid Pain Patch Revenue by Type (2020-2025)
4.2.2 Global Non-opioid Pain Patch Revenue by Type (2026-2031)
4.2.3 Global Non-opioid Pain Patch Revenue Market Share by Type (2020-2031)
4.3 Global Non-opioid Pain Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-opioid Pain Patch Sales by Application (2020-2031)
5.1.1 Global Non-opioid Pain Patch Sales by Application (2020-2025)
5.1.2 Global Non-opioid Pain Patch Sales by Application (2026-2031)
5.1.3 Global Non-opioid Pain Patch Sales Market Share by Application (2020-2031)
5.2 Global Non-opioid Pain Patch Revenue by Application (2020-2031)
5.2.1 Global Non-opioid Pain Patch Revenue by Application (2020-2025)
5.2.2 Global Non-opioid Pain Patch Revenue by Application (2026-2031)
5.2.3 Global Non-opioid Pain Patch Revenue Market Share by Application (2020-2031)
5.3 Global Non-opioid Pain Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Company Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Non-opioid Pain Patch Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Company Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Actavis Non-opioid Pain Patch Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Lingrui
6.5.1 Lingrui Company Information
6.5.2 Lingrui Description and Business Overview
6.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lingrui Non-opioid Pain Patch Product Portfolio
6.5.5 Lingrui Recent Developments/Updates
6.6 Teikoku Seiyaku
6.6.1 Teikoku Seiyaku Company Information
6.6.2 Teikoku Seiyaku Description and Business Overview
6.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
6.6.5 Teikoku Seiyaku Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Non-opioid Pain Patch Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Non-opioid Pain Patch Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Qizheng
6.9.1 Qizheng Company Information
6.9.2 Qizheng Description and Business Overview
6.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Qizheng Non-opioid Pain Patch Product Portfolio
6.9.5 Qizheng Recent Developments/Updates
6.10 Endo
6.10.1 Endo Company Information
6.10.2 Endo Description and Business Overview
6.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Endo Non-opioid Pain Patch Product Portfolio
6.10.5 Endo Recent Developments/Updates
6.11 Huarun 999
6.11.1 Huarun 999 Company Information
6.11.2 Huarun 999 Description and Business Overview
6.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
6.11.5 Huarun 999 Recent Developments/Updates
6.12 GSK
6.12.1 GSK Company Information
6.12.2 GSK Description and Business Overview
6.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GSK Non-opioid Pain Patch Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Haw Par
6.13.1 Haw Par Company Information
6.13.2 Haw Par Description and Business Overview
6.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Haw Par Non-opioid Pain Patch Product Portfolio
6.13.5 Haw Par Recent Developments/Updates
6.14 Nichiban
6.14.1 Nichiban Company Information
6.14.2 Nichiban Description and Business Overview
6.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nichiban Non-opioid Pain Patch Product Portfolio
6.14.5 Nichiban Recent Developments/Updates
6.15 Mentholatum
6.15.1 Mentholatum Company Information
6.15.2 Mentholatum Description and Business Overview
6.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Mentholatum Non-opioid Pain Patch Product Portfolio
6.15.5 Mentholatum Recent Developments/Updates
6.16 Laboratoires Genevrier
6.16.1 Laboratoires Genevrier Company Information
6.16.2 Laboratoires Genevrier Description and Business Overview
6.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
6.16.5 Laboratoires Genevrier Recent Developments/Updates
6.17 BLUE-EMU
6.17.1 BLUE-EMU Company Information
6.17.2 BLUE-EMU Description and Business Overview
6.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2020-2025)
6.17.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
6.17.5 BLUE-EMU Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Pain Patch Industry Chain Analysis
7.2 Non-opioid Pain Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Pain Patch Production Mode & Process Analysis
7.4 Non-opioid Pain Patch Sales and Marketing
7.4.1 Non-opioid Pain Patch Sales Channels
7.4.2 Non-opioid Pain Patch Distributors
7.5 Non-opioid Pain Patch Customer Analysis
8 Non-opioid Pain Patch Market Dynamics
8.1 Non-opioid Pain Patch Industry Trends
8.2 Non-opioid Pain Patch Market Drivers
8.3 Non-opioid Pain Patch Market Challenges
8.4 Non-opioid Pain Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Mylan NV
TEIKOKU SEIYAKU
Hisamitsu
Johnson & Johnson
Actavis
Lingrui
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Johnson & Johnson
List of Tables
 Table 1. Global Non-opioid Pain Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-opioid Pain Patch Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-opioid Pain Patch Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-opioid Pain Patch Sales (M Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-opioid Pain Patch Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-opioid Pain Patch Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-opioid Pain Patch Average Price (USD/K Units) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-opioid Pain Patch, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-opioid Pain Patch, Product Type & Application
 Table 12. Global Key Manufacturers of Non-opioid Pain Patch, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Patch as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-opioid Pain Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-opioid Pain Patch Sales by Region (2020-2025) & (M Units)
 Table 18. Global Non-opioid Pain Patch Sales Market Share by Region (2020-2025)
 Table 19. Global Non-opioid Pain Patch Sales by Region (2026-2031) & (M Units)
 Table 20. Global Non-opioid Pain Patch Sales Market Share by Region (2026-2031)
 Table 21. Global Non-opioid Pain Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-opioid Pain Patch Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-opioid Pain Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-opioid Pain Patch Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-opioid Pain Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
 Table 27. North America Non-opioid Pain Patch Sales by Country (2026-2031) & (M Units)
 Table 28. North America Non-opioid Pain Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-opioid Pain Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-opioid Pain Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
 Table 32. Europe Non-opioid Pain Patch Sales by Country (2026-2031) & (M Units)
 Table 33. Europe Non-opioid Pain Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-opioid Pain Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-opioid Pain Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-opioid Pain Patch Sales by Region (2020-2025) & (M Units)
 Table 37. Asia Pacific Non-opioid Pain Patch Sales by Region (2026-2031) & (M Units)
 Table 38. Asia Pacific Non-opioid Pain Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-opioid Pain Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-opioid Pain Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
 Table 42. Latin America Non-opioid Pain Patch Sales by Country (2026-2031) & (M Units)
 Table 43. Latin America Non-opioid Pain Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-opioid Pain Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-opioid Pain Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-opioid Pain Patch Sales by Country (2020-2025) & (M Units)
 Table 47. Middle East and Africa Non-opioid Pain Patch Sales by Country (2026-2031) & (M Units)
 Table 48. Middle East and Africa Non-opioid Pain Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-opioid Pain Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-opioid Pain Patch Sales (M Units) by Type (2020-2025)
 Table 51. Global Non-opioid Pain Patch Sales (M Units) by Type (2026-2031)
 Table 52. Global Non-opioid Pain Patch Sales Market Share by Type (2020-2025)
 Table 53. Global Non-opioid Pain Patch Sales Market Share by Type (2026-2031)
 Table 54. Global Non-opioid Pain Patch Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-opioid Pain Patch Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-opioid Pain Patch Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-opioid Pain Patch Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2020-2025)
 Table 59. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2026-2031)
 Table 60. Global Non-opioid Pain Patch Sales (M Units) by Application (2020-2025)
 Table 61. Global Non-opioid Pain Patch Sales (M Units) by Application (2026-2031)
 Table 62. Global Non-opioid Pain Patch Sales Market Share by Application (2020-2025)
 Table 63. Global Non-opioid Pain Patch Sales Market Share by Application (2026-2031)
 Table 64. Global Non-opioid Pain Patch Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-opioid Pain Patch Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-opioid Pain Patch Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-opioid Pain Patch Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2020-2025)
 Table 69. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2026-2031)
 Table 70. Hisamitsu Company Information
 Table 71. Hisamitsu Description and Business Overview
 Table 72. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 73. Hisamitsu Non-opioid Pain Patch Product
 Table 74. Hisamitsu Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 78. Mylan Non-opioid Pain Patch Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Non-opioid Pain Patch Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Actavis Company Information
 Table 86. Actavis Description and Business Overview
 Table 87. Actavis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 88. Actavis Non-opioid Pain Patch Product
 Table 89. Actavis Recent Developments/Updates
 Table 90. Lingrui Company Information
 Table 91. Lingrui Description and Business Overview
 Table 92. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 93. Lingrui Non-opioid Pain Patch Product
 Table 94. Lingrui Recent Developments/Updates
 Table 95. Teikoku Seiyaku Company Information
 Table 96. Teikoku Seiyaku Description and Business Overview
 Table 97. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 98. Teikoku Seiyaku Non-opioid Pain Patch Product
 Table 99. Teikoku Seiyaku Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 103. Sanofi Non-opioid Pain Patch Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 108. Novartis Non-opioid Pain Patch Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Qizheng Company Information
 Table 111. Qizheng Description and Business Overview
 Table 112. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 113. Qizheng Non-opioid Pain Patch Product
 Table 114. Qizheng Recent Developments/Updates
 Table 115. Endo Company Information
 Table 116. Endo Description and Business Overview
 Table 117. Endo Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 118. Endo Non-opioid Pain Patch Product
 Table 119. Endo Recent Developments/Updates
 Table 120. Huarun 999 Company Information
 Table 121. Huarun 999 Description and Business Overview
 Table 122. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 123. Huarun 999 Non-opioid Pain Patch Product
 Table 124. Huarun 999 Recent Developments/Updates
 Table 125. GSK Company Information
 Table 126. GSK Description and Business Overview
 Table 127. GSK Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 128. GSK Non-opioid Pain Patch Product
 Table 129. GSK Recent Developments/Updates
 Table 130. Haw Par Company Information
 Table 131. Haw Par Description and Business Overview
 Table 132. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 133. Haw Par Non-opioid Pain Patch Product
 Table 134. Haw Par Recent Developments/Updates
 Table 135. Nichiban Company Information
 Table 136. Nichiban Description and Business Overview
 Table 137. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 138. Nichiban Non-opioid Pain Patch Product
 Table 139. Nichiban Recent Developments/Updates
 Table 140. Mentholatum Company Information
 Table 141. Mentholatum Description and Business Overview
 Table 142. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 143. Mentholatum Non-opioid Pain Patch Product
 Table 144. Mentholatum Recent Developments/Updates
 Table 145. Laboratoires Genevrier Company Information
 Table 146. Laboratoires Genevrier Description and Business Overview
 Table 147. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 148. Laboratoires Genevrier Non-opioid Pain Patch Product
 Table 149. Laboratoires Genevrier Recent Developments/Updates
 Table 150. BLUE-EMU Company Information
 Table 151. BLUE-EMU Description and Business Overview
 Table 152. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
 Table 153. BLUE-EMU Non-opioid Pain Patch Product
 Table 154. BLUE-EMU Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Non-opioid Pain Patch Distributors List
 Table 158. Non-opioid Pain Patch Customers List
 Table 159. Non-opioid Pain Patch Market Trends
 Table 160. Non-opioid Pain Patch Market Drivers
 Table 161. Non-opioid Pain Patch Market Challenges
 Table 162. Non-opioid Pain Patch Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-opioid Pain Patch
 Figure 2. Global Non-opioid Pain Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-opioid Pain Patch Market Share by Type: 2024 & 2031
 Figure 4. Lidocaine Patches Product Picture
 Figure 5. Diclofenac Patches Product Picture
 Figure 6. Indomethacin Patches Product Picture
 Figure 7. Counter-Irritant Patches Product Picture
 Figure 8. Fentanyl Patches Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Non-opioid Pain Patch Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Non-opioid Pain Patch Market Share by Application: 2024 & 2031
 Figure 12. OTC
 Figure 13. Rx
 Figure 14. Global Non-opioid Pain Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Non-opioid Pain Patch Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Non-opioid Pain Patch Sales (2020-2031) & (M Units)
 Figure 17. Global Non-opioid Pain Patch Average Price (USD/K Units) & (2020-2031)
 Figure 18. Non-opioid Pain Patch Report Years Considered
 Figure 19. Non-opioid Pain Patch Sales Share by Manufacturers in 2024
 Figure 20. Global Non-opioid Pain Patch Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Non-opioid Pain Patch Players: Market Share by Revenue in Non-opioid Pain Patch in 2024
 Figure 22. Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Non-opioid Pain Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Non-opioid Pain Patch Sales Market Share by Country (2020-2031)
 Figure 25. North America Non-opioid Pain Patch Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Non-opioid Pain Patch Sales Market Share by Country (2020-2031)
 Figure 29. Europe Non-opioid Pain Patch Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Non-opioid Pain Patch Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Non-opioid Pain Patch Revenue Market Share by Region (2020-2031)
 Figure 37. China Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Non-opioid Pain Patch Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Non-opioid Pain Patch Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Non-opioid Pain Patch Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Non-opioid Pain Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Non-opioid Pain Patch by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Non-opioid Pain Patch by Type (2020-2031)
 Figure 59. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Non-opioid Pain Patch by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Non-opioid Pain Patch by Application (2020-2031)
 Figure 62. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2020-2031)
 Figure 63. Non-opioid Pain Patch Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Non Opioid Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pain Relief Patches Market Research Report 2025
Global Topical Pain Relief Patch Market Research Report 2024
Pain Relieving Patches Market
Transdermal Patch for Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medicated Adhesive Patch Market Insights Forecast to 2030
Transdermal Drug Delivery Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Adhesive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non opioid Pain Patches Market Research Report 2024
Global Transdermal Drug Delivery System Market Insights Forecast to 2030
Global Non opioid Analgesic Patch Market Research Report 2024
Global Non Opioid Pain Relief Device Market Research Report 2024
Global Flurbiprofen Gel Patch Market Research Report 2024
Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lidocaine Patch Market Research Report 2024
Global Buprenorphine Patches Market Research Report 2024
Global Loxoprofen Sodium Gel Patch Market Research Report 2024
Global Smart Drug releasing Patches Market Research Report 2025
Non Woven Medical Tape Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Menstrual Heat Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions